Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03892668Phase 4Completed
Phase 4, randomised, double-blind trial of tranexamic acid in uterine leiomyoma (3 arms), sponsored by Cairo University. Primary endpoint: Intraoperative Blood loss. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03892668.